Report of Foreign Issuer (6-k)
May 08 2020 - 6:17AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of May 2020
Commission
File Number 000-56026
TODOS
MEDICAL LTD.
(Translation
of registrant’s name into English)
1
Hamada Street
Rehovot,
Israel 2244427
Tel:
(011) (972) 8-633-3964
(Address
of Principal Executive Offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
|
[X]
Form 20-F
|
|
[ ]
Form 40-F
|
|
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
TODOS
MEDICAL LTD.
EXPLANATORY
NOTE
On April 24, 2020, Todos Medical USA, Inc.,
a subsidiary of the Company (“Todos”), entered into the Amended and Restated Collaboration Agreement with Emerald Organic
Products, Inc.(“Emerald”) pursuant to which Todos became the owner of 100% of the equity of Corona Diagnostics, LLC
and agreed to integrate its COVID-19 tests with Emerald’s telemedicine (Carie Health, Inc.) and independent pharmacy business
Bonsa Health, Inc. to create a full solution to help facilitate the screening and diagnosis of individuals potentially to identify
each indiciation’s COVID-19 PCR and/or antibody testing status to facilitate return to work programs in the United States.
This report on Form 6-K (including the exhibits hereto) shall not
be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)
and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly
set forth by specific reference in such filing.
EXHIBITS
Signature
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
TODOS
MEDICAL LTD.
|
|
|
|
By:
|
/s/
Gerald Commissiong
|
|
Name:
|
Gerald
Commissiong
|
|
Title:
|
Chief
Executive Officer
|
|
|
|
Date:
May 8, 2020
|
|
|
Todos Med (CE) (USOTC:TOMDF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Todos Med (CE) (USOTC:TOMDF)
Historical Stock Chart
From Apr 2023 to Apr 2024